ClinicalTrials.gov
public full text
Public Domain
Outcomes of Ablation of Unresectable Pancreatic Cancer Using the NanoKnife Irreversible Electroporation System-
The purpose of this study is to evaluate the short and intermediate term safety of the NanoKnife Irreversible Electroporation System when used off-label to treat unresectable pancreatic cancer. In addition, the study will evaluate the efficacy of this device in treating pain associated with unresectable pancreatic cancer. Quality of life post-procedure will also be collected.
Conceptio Open Archive
Analyze & explore related research in Conceptio
Connect this record directly into your research workflow or AI agent. Explore citations across open repositories, query full text, and export structured proof bundles.
This document is indexed with metadata only: full text is not available in the archive for this record. Open the official source ↗
Related documents
- Irreversible Electroporation Ablation for Colorectal Metastases to the Lung#1033519
- Combination of Irreversible Electroporation and NK Immunotherapy for Recurrent Liver Cancer#865185
- Active Anti-diabetic Treatment Plus Chemotherapy for Pancreatic Cancer Related Diabetes#234375
- Safety and Efficacy of PEG-Encapsulated Islet Allografts Implanted in Type I Diabetic Recipients#1172220
- New Perspective on Functionalized Metal Nanoparticles and Two-Dimensional Nanomaterials-Based Composites for Electrochemical Biomarker Sensing and Energy Storage Devices.#393020
Record · ID 1044600
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Retrieved via Conceptio: every document is proof-bundled with source, license, and retrieval metadata.
Bring this data into your agent: Connect via MCP or API · 20 free credits to start · no card required
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive
Read the Docs → · View CLI source on GitHub · Conceptio Open Knowledge Archive